GAMCO Investors’s Clovis Oncology, Inc. CLVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-145,400
| Closed | -$173K | – | 925 |
|
|
2022
Q3 | $173K | Sell |
145,400
-12,950
| -8% | -$15.4K | ﹤0.01% | 840 |
|
|
2022
Q2 | $285K | Sell |
158,350
-14,700
| -8% | -$26.5K | ﹤0.01% | 780 |
|
|
2022
Q1 | $350K | Buy |
173,050
+5,000
| +3% | +$10.1K | ﹤0.01% | 778 |
|
|
2021
Q4 | $455K | Sell |
168,050
-28,250
| -14% | -$76.5K | ﹤0.01% | 748 |
|
|
2021
Q3 | $875K | Sell |
196,300
-9,000
| -4% | -$40.1K | 0.01% | 651 |
|
|
2021
Q2 | $1.19M | Buy |
205,300
+7,850
| +4% | +$45.5K | 0.01% | 621 |
|
|
2021
Q1 | $1.39M | Sell |
197,450
-123,000
| -38% | -$863K | 0.01% | 570 |
|
|
2020
Q4 | $1.54M | Buy |
320,450
+8,150
| +3% | +$39.1K | 0.01% | 527 |
|
|
2020
Q3 | $1.82M | Sell |
312,300
-7,600
| -2% | -$44.3K | 0.02% | 476 |
|
|
2020
Q2 | $2.16M | Buy |
319,900
+8,300
| +3% | +$56K | 0.02% | 444 |
|
|
2020
Q1 | $1.98M | Buy |
311,600
+3,970
| +1% | +$25.3K | 0.02% | 429 |
|
|
2019
Q4 | $3.21M | Sell |
307,630
-61,745
| -17% | -$644K | 0.03% | 417 |
|
|
2019
Q3 | $1.45M | Buy |
369,375
+169,825
| +85% | +$668K | 0.01% | 540 |
|
|
2019
Q2 | $2.97M | Buy |
199,550
+144,850
| +265% | +$2.15M | 0.02% | 443 |
|
|
2019
Q1 | $1.36M | Buy |
+54,700
| New | +$1.36M | 0.01% | 535 |
|